Lin Yang

Dr Yang is a part-time professor of the MD Anderson Cancer Center, mainly engaged in cancer immunotherapy with CAR-T and CAR-NK cells. He presided over a number of clinical trials like the treatment of B - ALL / B - NHL with CD19 - CAR - T, the treatment of T - ALL with CD7 - CAR - NK, the treatment of solid tumors with (MUC1) - CAR - T and (MUC1) - CAR - NK. Several of these clinical trials are the first in the world and have achieved good results.